European Respiratory Society

FLAMOD against respiratory infections: phase I clinical trial of innovative new drug begins

20 March 2025 -- Lausanne, Switzerland -- A phase I clinical trial for a groundbreaking therapeutic innovation against respiratory infections has begun at the Clinical Investigation Centre of the Academic Hospital of Tours, France. The drug ‘FLAMOD’ is a treatment which aims to stimulate the body’s own defences rather than directly target the bacteria. FLAMOD...
4, Avenue Ste-Luce CH 1003 Lausanne Switzerland

+41 21 213 01 01